ER migraine relief: could a pill or spray replace the IV?
NCT ID NCT06985342
First seen May 01, 2026 · Last updated May 01, 2026
Summary
This study looked at whether two FDA-approved migraine medicines—a dissolving tablet (rimegepant) and a nasal spray (zavegepant)—work well in the emergency department. The goal was to see if they could provide fast pain relief and shorten ER visits compared to standard IV treatments. The study planned to enroll 100 adults with migraines but was terminated early after only 9 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE HEADACHES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mount Sinai Hospital
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.